Skip to main content
. 2019 May 1;11:3861–3868. doi: 10.2147/CMAR.S187011

Table 2.

Associations between LINC00673 variants and GC susceptibility

SNP Comparison Cases (n=1392) Controls (n=1364) OR (95% CI) a P-value
rs11655237 GG 775 838 1.00 (Reference)
AG 522 458 1.29 (1.07–1.54) 0.006
AA 95 68 1.58 (1.13–2.22) 0.008
A vs G 1.29 (1.12–1.48) 4.1×10−4
rs6501551 AA 1035 1023 1.00 (Reference)
AG 319 306 1.07 (0.72–1.59) 0.731
GG 38 35 1.15 (0.61–2.13) 0.756
G vs A 1.08 (0.81–1.45) 0.649
rs857510 GG 942 922 1.00 (Reference)
AG 415 404 1.05 (0.29–3.81) 0.946
AA 35 38 0.96 (0.78–1.19) 0.738
A vs G 1.03 (0.61–1.74) 0.906
rs9914618 GG 928 960 1.00 (Reference)
AG 414 363 1.23 (1.01–1.49) 0.042
AA 51 41 1.34 (0.84–2.13) 0.217
A vs G 1.21 (1.03–1.43) 0.023

Notes: aAdjusted for age, gender, BMI, WHR, family history of cancer, drinking status, and HP infection. Bold values indicate statistically significant.

Abbreviations: BMI, body mass index; GC, gastric cancer; HP, Helicobacter pylori; WHR, waist-hip-ratio.